trending Market Intelligence /marketintelligence/en/news-insights/trending/M43dUiJDS0tUT35U4W0hjw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

European Commission approves Advanced Accelerator's Somakit

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


European Commission approves Advanced Accelerator's Somakit

The European Commission has approved Advanced Accelerator Applications SA's SomaKit TOC.

Somakit is a kit for radiopharmaceutical preparation of gallium edotreotide solution for injection, for Positron Emission Tomography scans of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumors for localizing primary tumors and their metastases.

The drug has 10-year orphan market exclusivity in the European territory.